|Bid||0.00 x 800|
|Ask||0.00 x 2900|
|Day's Range||31.71 - 32.49|
|52 Week Range||30.78 - 39.45|
|Beta (3Y Monthly)||1.42|
|PE Ratio (TTM)||91.92|
|Earnings Date||Feb 1, 2019 - Feb 8, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||40.33|
Does Qiagen NV (NYSE:QGEN) represent a good buying opportunity at the moment? Let’s briefly check the hedge fund interest towards the company. Hedge fund firms constantly search out bright intellectuals and highly-experienced employees and throw away millions of dollars on research activities, so it is no wonder why they tend to generate millions in profits […]
When QIAGEN NV (NYSE:QGEN) announced its most recent earnings (30 September 2018), I compared it against two factor: its historical earnings track record, and the performance of its industry peers Read More...
Fast-tracking clinical readiness of test to support identification of patients eligible for novel Novartis PI3K inhibitor BYL719
The tie-up with NeoGenomics is expected to enable QIAGEN (QGEN) and pharmaceutical partners streamline the development and introduction of targeted drugs and companion diagnostics.
Partners discuss efforts to accelerate precision medicine solutions at ASH 2018 HILDEN, Germany and GERMANTOWN, Md. and FORT MYERS, Fla., Nov. 30, 2018 -- QIAGEN N.V. (NYSE:.
Partners discuss efforts to accelerate precision medicine solutions at ASH 2018
Highlighting Sample to Insight solutions for next-generation sequencing at American Society of Hematology 2018 meeting
Qiagen (QGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
NEW YORK, Nov. 13, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Read More...
The Vanguard Health Care Fund (Trades, Portfolio) released its third-quarter portfolio last week, listing four new positions. Warning! GuruFocus has detected 1 Warning Sign with ELAN. Managed by Jean Hynes, the fund invests in a number of diverse health care-related stocks from around the world in order to achieve long-term capital appreciation.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
Qiagen (QGEN) delivered earnings and revenue surprises of 6.06% and -1.11%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the Venlo, Netherlands-based company said it had profit of 26 cents. Earnings, adjusted for amortization costs and restructuring costs, were 35 cents per share. The results beat Wall ...
Sample to Insight solutions enabling deep analysis of disease-related genomic mutations
Adding QCI Analyze Universal to NGS bioinformatics offering, plus immuno-oncology content and additional features in analysis and interpretation